FRANKLIN WALLER: Open Payments
NPI 1497864607 · COLUMBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 21 payments from 10 companies in 2025. Trend: 2023 $566 · 2024 $812 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $148 |
| Lilly USA, LLC | 4 | $75 |
| Novo Nordisk Inc | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
Products named: AIRSUPRA, MOUNJARO, FARXIGA, DAYBUE, The Cologuard Plus Collection Kit, Rybelsus, UBRELVY, GEMTESA.
Industry payments across MS — which companies pay providers there.
